Keen-Hun Tai

Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial.

Paul Keall, Doan Trang Nguyen, Ricky O'Brien, Emily Hewson, Helen Ball, Per Poulsen, Jeremy Booth, Peter Greer, Perry Hunter, Lee Wilton, Regina Bromley, John Kipritidis, Thomas Eade, Andrew Kneebone, George Hruby, Trevor Moodie, Amy Hayden, Sandra Turner, Sankar Arumugam, Mark Sidhom, et al.

Journal article  |  2020  |  International Journal of Radiation Oncology*Biology*Physics

PURPOSE: Kilovoltage intrafraction monitoring (KIM) is a novel software platform implemented on standard radiation therapy systems..

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial

David Joseph, James W Denham, Allison Steigler, David S Lamb, Nigel A Spry, John Stanley, Tom Shannon, Gillian Duchesne, Chris Atkinson, John HL Matthews, Sandra Turner, Lizbeth Kenny, David Christie, Keen-Hun Tai, Nirdosh Kumar Gogna, Rachel Kearvell, Judy Murray, Martin A Ebert, Annette Haworth, Brett Delahunt, et al.

Journal article  |  2020  |  International Journal of Radiation Oncology*Biology*Physics

The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial

Emily A Hewson, Doan Trang Nguyen, Ricky O'Brien, Jung-Ha Kim, Tim Montanaro, Trevor Moodie, Peter B Greer, Nicholas Hardcastle, Thomas Eade, Andrew Kneebone, George Hruby, Amy J Hayden, Sandra Turner, Shankar Siva, Keen-Hun Tai, Perry Hunter, Joshua Sams, Per Rugaard Poulsen, Jeremy T Booth, Jarad Martin, et al.

Journal article  |  2019  |  Medical Physics

TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol

Jarad Martin, Paul Keall, Shankar Siva, Peter Greer, David Christie, Kevin Moore, Jason Dowling, David Pryor, Peter Chong, Nicholas McLeod, Avi Raman, James Lynam, Joanne Smart, Christopher Oldmeadow, Colin I Tang, Declan G Murphy, Jeremy Millar, Keen Hun Tai, Lois Holloway, Penny Reeves, et al.

Journal article  |  2019  |  BMJ Open

INTRODUCTION: Stereotactic body radiotherapy (SBRT) is a non-invasive alternative to surgery for the treatment of non-metastatic p..

Is MLC Tracking Or Gating a Better Real-Time Correction Strategy? An Analysis of the TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) Trial

E Hewson, D Nguyen, R O'Brien, P Poulsen, J Booth, P Greer, T Eade, A Kneebone, G Hruby, T Moodie, A Hayden, S Turner, N Hardcastle, S Siva, K Tai, J Martin, P Keall

Conference Proceedings  |  2019  |  MEDICAL PHYSICS

Real-Time tracking improves treatment: The TROG Stereo Prostate Ablative Radiotherapy with KIM trial

P Keall, DT Nguyen, R O'Brien, E Hewson, H Ball, P Poulsen, J Booth, P Greer, P Hunter, L Wilton, R Bromley, J Kipritidis, T Eade, A Kneebone, G Hruby, T Moodie, A Hayden, S Turner, S Arumugam, M Sidhom, et al.

Conference Proceedings  |  2019  |  Radiotherapy and Oncology

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

James W Denham, David Joseph, David S Lamb, Nigel A Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen-Hun Tai, David Christie, Lizbeth Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Chris Oldmeadow, John Attia, Allison Steigler

Journal article  |  2019  |  The Lancet Oncology

Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials

DA Loblaw, J Bassett, C D'Este, G Pond, P Cheung, M Frydenberg, MT King, H Lukka, S Malone, JL Millar, RL Milne, T Pickles, R Smith, MR Stockler, S Turner, KH Tai, H Woo, G Duchesne

Conference Proceedings  |  2018  |  International Journal of Radiation Oncology*Biology*Physics

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial

Shankar Siva, Mathias Bressel, Declan G Murphy, Mark Shaw, Sarat Chander, John Violet, Keen Hun Tai, Cristian Udovicich, Andrew Lim, Lisa Selbie, Michael S Hofman, Tomas Kron, Daniel Moon, Jeremy Goad, Nathan Lawrentschuk, Farshad Foroudi

Journal article  |  2018  |  European Urology

Timing of androgen deprivation therapy for prostate cancer patients after radiation: Planned combined analysis of two randomized phase 3 trials.

Andrew Loblaw, Julie Bassett, Catherine D'Este, Gregory Russell Pond, Patrick Cheung, Jeremy Laurence Millar, Mark Frydenberg, Madeleine Trudy King, Himu Lukka, Shawn Malone, Roger L Milne, Tom Pickles, Rosemary Smith, Martin R Stockler, Sandra Turner, Keen Hun Tai, Henry Woo, Gillian M Duchesne

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Moderate hypofractionation for prostate cancer: A user's guide

David I Pryor, Sandra L Turner, Keen Hun Tai, Colin Tang, Giuseppe Sasso, Marcus Dreosti, Henry H Woo, Lee Wilton, Jarad M Martin

Journal article  |  2018  |  Journal of Medical Imaging and Radiation Oncology

Pembrolizumab and chemoradiotherapy for muscle invasive bladder cancer: The ANZUP 1502 PCR-MIB trial.

Andrew James Weickhardt, Farshad Foroudi, Shomik Sengupta, Laura Galletta, Alan Herschtal, Peter S Grimison, Nitya Patanjali, Siobhan Ng, Colin Tang, Robert Goodwin, Elizabeth J Hovey, Tom Jarvis, Colin Chen, Shahneen Kaur Sandhu, Keen Hun Tai, Nathan Lawrentschuk, Ian D Davis

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Patterns of health services utilization in the last two weeks of life among cancer patients: Experience in an Australian academic cancer center

Wee Loon Ong, Richard Khor, Mathias Bressel, Phillip Tran, Jo Tedesco, Keen Hun Tai, David Ball, Gillian Duchesne, Farshad Foroudi

Journal article  |  2017  |  Asia-Pacific Journal of Clinical Oncology

Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Gillian M Duchesne, Henry H Woo, Madeleine King, Steven J Bowe, Martin R Stockler, Alice Ames, Catherine D'Este, Mark Frydenberg, Andrew Loblaw, Shawn Malone, Jeremy Millar, Keen Hun Tai, Sandra Turner

Journal article  |  2017  |  The Lancet Oncology

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

Charles N Catton, Himu Lukka, Chu-Shu Gu, Jarad M Martin, Stephane Supiot, Peter WM Chung, Glenn S Bauman, Jean-Paul Bahary, Shahida Ahmed, Patrick Cheung, Keen Hun Tai, Jackson S Wu, Matthew B Parliament, Theodoros Tsakiridis, Tom B Corbett, Colin Tang, Ian S Dayes, Padraig Warde, Tim K Craig, Jim A Julian, et al.

Journal article  |  2017  |  Journal of Clinical Oncology

Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients

Sweet Ping Ng, Gillian Duchesne, Keen-Hun Tai, Farshad Foroudi, Gargi Kothari, Scott Williams

Journal article  |  2017  |  Prostate International

Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial

Swetha Sridharan, Allison Steigler, Nigel A Spry, David Joseph, David S Lamb, John H Matthews, Chris Atkinson, Keen-Hun Tai, Gillian Duchesne, David Christie, John Attia, Elizabeth G Holliday, James W Denham

Journal article  |  2016  |  RADIOTHERAPY AND ONCOLOGY

Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial

Penelope Schofield, Karla Gough, Kerryann Lotfi-Jam, Rebecca Bergin, Anna Ugalde, Paul Dudgeon, Wallace Crellin, Kathryn Schubach, Farshard Foroudi, Keen Hun Tai, Gillian Duchesne, Rob Sanson-Fisher, Sanchia Aranda

Journal article  |  2016  |  BMC CANCER

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Gillian M Duchesne, Henry H Woo, Julie K Bassett, Steven J Bowe, Catherine D'Este, Mark Frydenberg, Madeleine King, Leo Ledwich, Andrew Loblaw, Shawn Malone, Jeremy Millar, Roger Milne, Rosemary G Smith, Nigel Spry, Martin Stockler, Rodney A Syme, Keen Hun Tai, Sandra Turner

Journal article  |  2016  |  The Lancet Oncology

A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes.

Raymond Wu, Hannah Woodford, Anne Capp, Perry Hunter, Gary Cowin, Keen-Hun Tai, Paul L Nguyen, Peter Chong, Jarad Martin

Journal article  |  2015  |  Radiation Oncology

BACKGROUND: A prospective clinical trial was conducted to evaluate the feasibility of a novel approach to the treatment of patient..

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial

James W Denham, Allison Steigler, David Joseph, David S Lamb, Nigel A Spry, Gillian Duchesne, Chris Atkinson, John Matthews, Sandra Turner, Lizbeth Kenny, Keen-Hun Tai, Nirdosh Kumar Gogna, Suki Gill, Hendrick Tan, Rachel Kearvell, Judy Murray, Martin Ebert, Annette Haworth, Angel Kennedy, Brett Delahunt, et al.

Journal article  |  2015  |  Radiotherapy and Oncology

Tolerability and outcomes of curative radiotherapy in patients aged 85 or more years

Richard C Khor, Mathias Bressel, Jo Tedesco, Keen Hun Tai, David L Ball, Gillian M Duchesne, Helen Farrugia, Wai Kuan Yip, Farshad Foroudi

Journal article  |  2015  |  Medical Journal of Australia

Efficacy of High-dose Palliative Radiotherapy for Localised, Castration-resistant Prostate Cancer

R White, R Khor, M Bressel, G Duchesne, S Williams, P Bowden, K Tai, F Foroudi

Journal article  |  2015  |  Clinical Oncology

Prostate Bed Radiation Therapy: The Utility of Ultrasound Volumetric Imaging of the Bladder

A Haworth, A Paneghel, M Bressel, A Herschtal, D Pham, KH Tai, R Oates, J Gawthrop, A Cray, F Foroudi

Journal article  |  2014  |  Clinical Oncology

Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer

James W Denham, Michael Nowitz, David Joseph, Gillian Duchesne, Nigel A Spry, David S Lamb, John Matthews, Sandra Turner, Chris Atkinson, Keen-Hun Tai, Nirdosh Kumar Gogna, Lizbeth Kenny, Terry Diamond, Richard Smart, David Rowan, Pablo Moscato, Renato Vimieiro, Richard Woodfield, Kevin Lynch, Brett Delahunt, et al.

Journal article  |  2014  |  BJU International

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

James W Denham, David Joseph, David S Lamb, Nigel A Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen-Hun Tai, David Christie, Lizbeth Kenny, Sandra Turner, Nirdosh Kumar Gogna, Terry Diamond, Brett Delahunt, Christopher Oldmeadow, John Attia, Allison Steigler

Journal article  |  2014  |  The Lancet Oncology

Seminal vesicle intrafraction motion analysed with cinematic magnetic resonance imaging

Suki Gill, Kim Dang, Chris Fox, Mathias Bressel, Tomas Kron, Noelene Bergen, Nick Ferris, Rebecca Owen, Sarat Chander, Keen Hun Tai, Farshad Foroudi

Journal article  |  2014  |  Radiation Oncology

Risk factors for radiotherapy incidents and impact of an online electronic reporting system

David W Chang, Lynn Cheetham, Luc te Marvelde, Mathias Bressel, Tomas Kron, Suki Gill, Keen Hun Tai, David Ball, William Rose, Linas Silva, Farshad Foroudi

Journal article  |  2014  |  Radiotherapy and Oncology

FROGG high-risk prostate cancer workshop: Patterns of practice and literature review. Part II post-radical prostatectomy

Margot Lehman, Mark Sidhom, Andrew B Kneebone, Amy J Hayden, Jarad M Martin, David Christie, Marketa Skala, Keen-Hun Tai

Journal article  |  2014  |  Journal of Medical Imaging and Radiation Oncology

FROGG high-risk prostate cancer workshop: Patterns of practice and literature review Part I: Intact prostate

Margot Lehman, Amy J Hayden, Jarad M Martin, David Christie, Andrew B Kneebone, Mark Sidhom, Marketa Skala, Keen-Hun Tai

Journal article  |  2014  |  Journal of Medical Imaging and Radiation Oncology

Conventional margins not sufficient for post-prostatectomy prostate bed coverage: An analysis of 477 cone-beam computed tomography scans

Suki Gill, Rajesh Isiah, Rohan Adams, Kim Dang, Shankar Siva, Keen Hun Tai, Tomas Kron, Farshad Foroudi

Journal article  |  2014  |  Radiotherapy and Oncology

Patterns of retreatment with radiotherapy in a large academic centre

Richard Khor, Mathias Bressel, Keen Hun Tai, David Ball, Gillian Duchesne, William Rose, Jo Tedesco, Suki Gill, Claire Fitzpatrick, Farshad Foroudi

Journal article  |  2013  |  Journal of Medical Imaging and Radiation Oncology

Management of bone metastases

KH Tai, F Foroudi

Book Chapter  |  2013

Late toxicity and biochemical control in with and without dose escalated image 554 prostate cancer patients treated guided radiotherapy

David Kok, Suki Gill, Mathias Bressel, Keelan Byrne, Tomas Kron, Chris Fox, Gillian Duchesne, Keen Hun Tai, Farshad Foroudi

Journal article  |  2013  |  Radiotherapy and Oncology

Plan of the day selection for online image-guided adaptive post-prostatectomy radiotherapy

Suki Gill, Daniel Pham, Kim Dang, Mathias Bressel, Tomas Kron, Shankar Siva, Phillip K Tran, Keen Hun Tai, Farshad Foroudi

Journal article  |  2013  |  Radiotherapy and Oncology

Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer.

James W Denham, Allison Steigler, Keen-Hun Tai, David Joseph, John Matthews, Chris Atkinson, Nigel A Spry, Sandra Turner, John North, David Christie, Chris Wynne, David S Lamb

Journal article  |  2013  |  Radiotherapy and Oncology

PURPOSE: In the TROG 96.01 trial 6 month neo-adjuvant androgen suppression (NAS) and radiotherapy (RT) for locally advanced prosta..

Ten-year results of quality assurance in radiotherapy chart round

Bardia Taghavi Bayat, Suki Gill, Shankar Siva, Keen Hun Tai, Michael Lim Joon, Farshad Foroudi

Journal article  |  2013  |  BMC Health Services Research

Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study

Mary Leahy, Meinir Krishnasamy, Alan Herschtal, Mathias Bressel, Tracey Dryden, Keen Hun Tai, Farshad Foroudi

Journal article  |  2013  |  European Journal of Oncology Nursing

Direct 2-Arm Comparison Shows Benefit of High-Dose-Rate Brachytherapy Boost vs External Beam Radiation Therapy Alone for Prostate Cancer

Richard Khor, Gillian Duchesne, Keen-Hun Tai, Farshad Foroudi, Sarat Chander, Sylvia Van Dyk, Margaret Garth, Scott Williams

Journal article  |  2013  |  International Journal of Radiation: Oncology - Biology - Physics

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

James W Denham, Chantelle Wilcox, David Joseph, Nigel A Spry, David S Lamb, Keen-Hun Tai, John Matthews, Chris Atkinson, Sandra Turner, David Christie, Nirdosh Kumar Gogna, Lizbeth Kenny, Gillian Duchesne, Brett Delahunt, Patrick McElduff

Journal article  |  2012  |  Lancet Oncology

Cost Minimisation Analysis: Kilovoltage Imaging with Automated Repositioning Versus Electronic Portal Imaging in Image-guided Radiotherapy for Prostate Cancer

S Gill, S Younie, A Rolfo, J Thomas, S Siva, C Fox, T Kron, D Phillips, KH Tai, F Foroudi

Journal article  |  2012  |  Clinical Oncology

A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer

Farshad Foroudi, Lesley Wilson, Mathias Bressel, Annette Haworth, Colin Hornby, Daniel Pham, Jim Cramb, Suki Gill, Keen Hun Tai, Tomas Kron

Journal article  |  2012  |  Radiation Oncology

Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy

S Gill, J Li, J Thomas, M Bressel, K Thursky, C Styles, KH Tai, GM Duchesne, F Foroudi

Journal article  |  2012  |  British Journal of Radiology

HIGH-DOSE-RATE BRACHYTHERAPY AS A MONOTHERAPY FOR FAVORABLE-RISK PROSTATE CANCER: A PHASE II TRIAL

Maroie Barkati, Scott G Williams, Farshad Foroudi, Keen Hun Tai, Sarat Chander, Sylvia van Dyk, Andrew See, Gillian M Duchesne

Journal article  |  2012  |  International Journal of Radiation: Oncology - Biology - Physics

Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: A planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique

Brandon T Nguyen, Colin Hornby, Tomas Kron, Jim Cramb, Aldo Rolfo, Pham Daniel, Annette Haworth, Keen-Hun Tai, Farshad Foroudi

Journal article  |  2012  |  Journal of Medical Imaging and Radiation Oncology

Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder

Benjamin R Hindson, Sandra L Turner, Jeremy L Millar, Farshad Foroudi, N Kumar Gogna, Marketa Skala, Andrew Kneebone, David RH Christie, Margot Lehman, Kirsty L Wiltshire, Keen-Hun Tai

Journal article  |  2012  |  Journal of Medical Imaging and Radiation Oncology

Electronic portal imaging vs kilovoltage imaging in fiducial marker image-guided radiotherapy for prostate cancer: an analysis of set-up uncertainties

S Gill, J Thomas, C Fox, T Kron, A Thompson, S Chander, S Williams, KH Tai, G Duchesne, F Foroudi

Journal article  |  2012  |  British Journal of Radiology

Interfraction patient motion and implant displacement in prostate high dose rate brachytherapy

CD Fox, T Kron, M Leahy, G Duchesne, S Williams, KH Tai, A Haworth, A Herschtal, F Foroudi

Journal article  |  2011  |  Medical Physics

ONLINE ADAPTIVE RADIOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: RESULTS OF A PILOT STUDY

Farshad Foroudi, Jacky Wong, Tomas Kron, Aldo Rolfo, Annetre Haworth, Paul Roxby, Jessica Thomas, A Herschtal, Daniel Pham, Scott Williams, Keen Hun Tai, Gillian Duchesne

Journal article  |  2011  |  International Journal of Radiation: Oncology - Biology - Physics

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy

Suki Gill, Jessica Thomas, Chris Fox, Tomas Kron, Aldo Rolfo, Mary Leahy, Sarat Chander, Scott Williams, Keen Hun Tai, Gillian M Duchesne, Farshad Foroudi

Journal article  |  2011  |  Radiation Oncology

In Pursuit of Individualised Margins for Prostate Cancer Patients Undergoing Image-guided Radiotherapy: The Effect of Body Mass Index on Intrafraction Prostate Motion

AL Thompson, S Gill, J Thomas, T Kron, C Fox, A Herschtal, KH Tai, F Foroudi

Journal article  |  2011  |  Clinical Oncology

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

James W Denham, Allison Steigler, David S Lamb, David Joseph, Sandra Turner, John Matthews, Chris Atkinson, John North, David Christie, Nigel A Spry, Keen-Hun Tai, Chris Wynne, Catherine D'Este

Journal article  |  2011  |  Lancet Oncology

Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma

AJ Hayden, JM Martin, AB Kneebone, M Lehman, KL Wiltshire, M Skala, D Christie, P Vial, R McDowall, K-H Tai

Journal article  |  2010  |  Journal of Medical Imaging and Radiation Oncology

Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers

Tomas Kron, Jessica Thomas, Chris Fox, Ann Thompson, Rebecca Owen, Alan Herschtal, Annette Haworth, Keen-Hun Tai, Farshad Foroudi

Journal article  |  2010  |  Radiotherapy and Oncology

Extraction of data for margin calculations in prostate radiotherapy from a commercial record and verify system

C Fox, R Fisher, T Kron, KH Tai, A Thompson, R Owen, F Foroudi

Journal article  |  2010  |  Journal of Medical Imaging and Radiation Oncology

Development and evaluation of a training program for therapeutic radiographers as a basis for online adaptive radiation therapy for bladder carcinoma

F Foroudi, J Wong, T Kron, P Roxby, A Haworth, A Bailey, A Rolfo, A Paneghel, C Styles, M Laferlita, KH Tai, S Williams, G Duchesne

Journal article  |  2010  |  Radiography

Prospective development of an individualised predictive model for treatment coverage using offline cone beam computed tomography surrogate measures in post-prostatectomy radiotherapy

PK Tran, A Haworth, F Foroudi, A Paneghel, AG Herschtal, KH Tai, SG Williams, S Soteriou, M Laferlita, GM Duchesne

Journal article  |  2009  |  Journal of Medical Imaging and Radiation Oncology

Rectal Filling at Planning Does Not Predict Stability of the Prostate Gland during a Course of Radical Radiotherapy if Patients with Large Rectal Filling are Re-imaged

AL Stillie, T Kron, C Fox, A Herschtal, A Haworth, A Thompson, R Owen, KH Tai, G Duchesne, F Foroudi

Journal article  |  2009  |  Clinical Oncology

Obtaining information on intra-fraction prostate displacement in radiotherapy determined from pre- and post-treatment kV imaging

T Kron, J Thomas, C Fox, A Thompson, R Owen, A Herschtal, A Haworth, KH Tai, F Foroudi

Conference Proceedings  |  2009  |  IFMBE Proceedings

Measuring time to biochemical failure in the TROG 96.01 trial: when should the clock start ticking?

James W Denham, Allison Steigler, Mahesh Kumar, David S Lamb, David Joseph, Nigel A Spry, Keen-Hun Tai, Chris Atkinson, Sandra Turner, Peter B Greer, Paul S Gleeson, Catherine D'Este

Journal article  |  2009  |  International Journal of Radiation Oncology*Biology*Physics

PURPOSE: We sought to determine whether short-term neoadjuvant androgen deprivation (STAD) duration influences the optimal time po..

Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?

James W Denham, Allison Steigler, Chantelle Wilcox, David S Lamb, David Joseph, Chris Atkinson, Keen-Hun Tai, Nigel A Spry, Paul S Gleeson, Catherine D'Este

Journal article  |  2009  |  Cancer

BACKGROUND: The value of pretreatment (initial) prostate-specific antigen (iPSA) and biochemical recurrence (BR) as prognostic fac..

Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer.

James W Denham, Mahesh Kumar, Paul S Gleeson, David S Lamb, David Joseph, Chris Atkinson, John Matthews, Keen-Hun Tai, Nigel A Spry, David Christie, Sandra Turner, Peter B Greer, Catherine D'Este, Allison Steigler

Journal article  |  2009  |  International Journal of Radiation Oncology*Biology*Physics

PURPOSE: We studied prostate-specific antigen (PSA) changes after radiation with or without neoadjuvant androgen deprivation to de..

Urethral stricture following high dose rate brachytherapy for prostate cancer

Lisa Sullivan, Scott G Williams, Keen Hun Tai, Farshad Foroudi, L Cleeve, Gillian M Duchesne

Journal article  |  2009  |  Radiotherapy and Oncology

Offline adaptive radiotherapy for bladder cancer using cone beam computed tomography

F Foroudi, J Wong, A Haworth, A Baille, J McAlpine, A Rolfo, T Kron, P Roxby, A Paneghel, S Williams, G Duchesne, KH Tai

Journal article  |  2009  |  Journal of Medical Imaging and Radiation Oncology

Verification of target position in the post-prostatectomy cancer patient using cone beam CT

A Haworth, A Paneghel, A Herschtal, G Duchesne, S Williams, KH Tai, T Kron, P Roxby, S Soteriou, M Laferlita, F Foroudi

Journal article  |  2009  |  Journal of Medical Imaging and Radiation Oncology

Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial

Anne Capp, Mario Inostroza-Ponta, Dana Bill, Pablo Moscato, Chi Lai, David Christie, David Lamb, Sandra Turner, David Joseph, John Matthews, Chris Atkinson, John North, Michael Poulsen, Nigel A Spry, Keen-Hun Tai, Chris Wynne, Gillian Duchesne, Allison Steigler, James W Denham

Journal article  |  2009  |  Radiotherapy and Oncology

Inter-observer variability of clinical target volume delineation for bladder cancer using CT and cone beam CT

F Foroudi, A Haworth, A Pangehel, J Wong, P Roxby, G Duchesne, S Williams, KH Tai

Journal article  |  2009  |  Journal of Medical Imaging and Radiation Oncology

Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial.

James W Denham, Allison Steigler, Chantelle Wilcox, David S Lamb, David Joseph, Chris Atkinson, John Matthews, Keen-Hun Tai, Nigel A Spry, David Christie, Paul S Gleeson, Peter B Greer, Catherine D'Este, undefined Trans-Tasman Radiation Oncology Group 96.01 Trialists

Journal article  |  2008  |  The Lancet Oncology

BACKGROUND: Surrogate endpoints for prostate cancer-specific mortality after curative primary treatment are not well established. ..

Planning and implementing an implanted fiducial programme for prostate cancer radiation therapy

A Thompson, C Fox, F Foroudi, C Styles, KH Tai, R Owen, M Laferlita

Journal article  |  2008  |  Journal of Medical Imaging and Radiation Oncology

Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group

Mark A Sidhom, Andrew B Kneebone, Margot Lehman, Kirsty L Wiltshire, Jeremy L Millar, Rahul K Mukherjee, Thomas P Shakespeare, Keen-Hun Tai

Journal article  |  2008  |  Radiotherapy and Oncology

Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: Mature prospective phase I/II study results

Gillian Mary Duchesne, Scott Garrick Williams, Ram Das, Keen Hun Tai

Journal article  |  2007  |  Radiotherapy and Oncology

Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.

Anthony V D'Amico, James W Denham, Juanita Crook, Ming-Hui Chen, Samuel Z Goldhaber, David S Lamb, David Joseph, Keen-Hun Tai, Shawn Malone, Charles Ludgate, Allison Steigler, Philip W Kantoff

Journal article  |  2007  |  Journal of Clinical Oncology

PURPOSE: We evaluated whether the timing of fatal myocardial infarction (MI) was influenced by the administration of androgen supp..

Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.

Anthony V D'Amico, James W Denham, Michel Bolla, Laurence Collette, David S Lamb, Keen-Hun Tai, Allison Steigler, Ming-Hui Chen

Journal article  |  2007  |  Cancer

BACKGROUND: The study evaluated whether the use of 3 years as compared with 6 months of androgen suppression therapy (AST) combine..

A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?

Johann I Tang, Scott G Williams, Keen Hun Tai, Joanne Dean, Gillian M Duchesne

Journal article  |  2006  |  Brachytherapy

Delayed rectal and urinary symptomatotogy in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation

D Christie, J Denham, A Steigler, D Lamb, S Turner, H Mameghan, D Joseph, J Matthews, I Franklin, C Atkinson, J North, M Poulsen, NA Spry, KH Tai, C Wynne, G Duchesne, O Kovacev, L Francis, A Kramar, C D'Este, et al.

Journal article  |  2005  |  Radiotherapy and Oncology

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

JW Denham, A Steigler, DS Lamb, D Joseph, H Mameghan, S Turner, J Matthews, I Franklin, C Atkinson, J North, M Poulsen, D Christie, NA Spry, KH Tai, C Wynne, G Duchesne, O Kovacev, C D'Este

Journal article  |  2005  |  Lancet Oncology

Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer.

M Skala, M Berry, G Duchesne, K Gogna, K-H Tai, S Turner, A Kneebone, A Rolfo, A Haworth

Journal article  |  2004  |  Australasian Radiology

Three-dimensional conformal radiation therapy (3DCRT) has been shown to reduce normal tissue toxicity and allow dose escalation in..

Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop.

K-H Tai, G Duchesne, S Turner, A Kneebone, A See, K Gogna, M Berry

Journal article  |  2004  |  Australasian Radiology

There is an increasing use of 3-D conformal radiotherapy (3DCRT) in the radiotherapeutic management of prostate cancer. The Facult..

Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer

DS Lamb, JW Denham, H Mameghan, D Joseph, S Turner, J Matthews, I Franklin, C Atkinson, J North, M Poulsen, O Kovacev, R Robertson, L Francis, D Christie, NA Spry, KH Tai, C Wynne, G Duchesne

Journal article  |  2003  |  Radiotherapy and Oncology